Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Reexamination Certificate
2000-05-23
2004-05-11
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
C424S400000, C424S422000, C424S423000, C424S426000, C424S443000, C424S444000, C424S484000, C424S486000, C514S772000, C514S772300, C514S777000, C514S781000, C514S944000
Reexamination Certificate
active
06733788
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to thermosensitive hydrogels loaded with solute materials, and more particularly, to the delivery of biologically active solute materials to target locations within a mammalian body using thermosensitive cellulose gels.
BACKGROUND OF THE INVENTION
Hydrogels are crosslinked networks of biological, synthetic, or semi-synthetic polymers. Because hydrogel polymer chains are held together by crosslinks, hydrogels behave like solids rather than liquids, despite the fact that they contain at least 20% water by weight. A significant property of hydrogels is the equilibrium degree of swelling (“Q”), which is the amount of water absorbed by the gel expressed as the ratio of swollen gel volume (or mass) to dry gel volume (or mass). Many hydrogels are responsive to external stimuli in that they expel or absorb water in response to changes in pH, electric field, light intensity, pressure, indirect chemical stimuli, and temperature. The resulting change in hydrogel water content results in a corresponding reversible change in volume.
Hydrogels have many technological uses in both medical and non-medical fields. Owing to their often good biocompatibility and easily adjustable permeability, hydrogels have been used in a range of biomedical applications including contact lenses, diapers, soft and hard tissue prostheses and bioartificial organs.
One of the most interesting potential biomedical applications for hydrogels is the use of these gels as vehicles for the delivery of biologically active solutes. In such an application, the biologically active solute is A absorbed into the gel as a solute and thereafter released from the gel over time. The localized delivery of biologically active materials is described, for example, in U.S. Pat. Nos. 5,304,121, 5,674,192 and 5,588,962, and in A. Gutowska et al., “Heparin Release from Thermosensitive Polymer Coatings: In vivo Studies,” 29
J. Biomed. Matls. Res.
811 (1995), each of which is incorporated herein by reference.
Hydrogels are attractive for the delivery of peptide or protein-drugs because they provide a hydrophilic environment for proteins and thus help preserve their activities. Most therapeutic proteins are vulnerable to the proteases in the digestive tract and also have difficulty crossing the skin and other barrier membranes. Implantable drug release systems are thus a viable alternative for delivering therapeutic proteins. Recently, pH-sensitive hydrogels based on poly (N-isopropylacrylamide) (“PNIPA”) have been proposed for enteric drug delivery. In such a system, the gel is collapsed at gastric pH for the negligible release of protein, whereas the gel swells at enteric pH thus permitting sustained release within the intestines.
Hydrogels that undergo reversible volume changes in response to changes in temperature are known as thermosensitive gels. These gels shrink at a transition temperature that is related to the lower critical solution temperature (“LCST”) of the linear polymer from which the gel is made. Specifically, typical thermosensitive gels have an affinity for water and thus swell at temperatures below the transition temperature, whereas they expel water and thus shrink or “deswell” at temperatures above the transition temperature. Thermosensitive hydrogels are potentially of significant utility in biomedical applications, particularly as a means for localized drug delivery. PNIPA is an example of a known thermosensitive hydrogel, as described in R. Dinarvand et al., “The Use of Thermosensitive Hydrogels for On-off Release of Molecules,” 36
J. Controlled Release
221 (1995); A. Gutowska et al., “Thermosensitive Interpenetrating Polymer Networks: Synthesis, Characterization, and Macromolecular Release,” 27
Macromolecules
4167 (1994); R. Yoshida et al., “Drug Release Profiles in the Shrinking Process of Thermoresponsive Poly(N-isopropylacrtlamide-co-alkyl methacrylate) Gels,” 31
Ind. Eng. Chem
. Res. 2339 (1992); and Y. Han Bae et al., “Thermo-sensitive Polymers as On-off Switches for Drug Delivery,” 8
Makromol. Chem., Rapid Commun.
481 (1987), each of which is incorporated herein by reference.
Known thermosensitive hydrogels such as PNIPA generally become impermeable to solute when these gels deswell. Consequently, such hydrogels are not applicable to drug delivery systems wherein drug release corresponds to an increase in temperature to above the hydrogel transition temperature. In addition, known thermosensitive hydrogels (e.g., PNIPA) are generally of questionable or uncertain biocompatibility to be safely used in desired drug delivery applications, and as such, FDA approval for the use of PNIPA as part of solute delivery systems remains questionable. Moreover, means for the use of thermosensitive hydrogels in specific localized drug delivery systems have not been detailed in the literature.
SUMMARY OF THE INVENTION
In one aspect, the present invention includes a system for delivering solute to a target location within a mammalian body, the system comprising a medical device, a thermosensitive cellulose gel structure over the medical device, and a solute within the gel structure. In one embodiment, the gel deswells and expels the solute with an increase in gel temperature.
In another aspect, the present invention includes a method of delivering solute to a target location, the method comprising the steps of providing a thermosensitive cellulose gel structure, wherein the gel structure is loaded with a solute, positioning the loaded gel structure to the target location, and increasing the temperature of the loaded gel structure from an initial temperature to a temperature higher than the initial temperature. In one embodiment, the step of increasing the temperature of the loaded gel structure results in the deswelling of the gel, thus releasing the solute. In a further embodiment, the target location is located within a mammalian body, the substrate is a medical device, the solute is a biologically active solute, and the step of increasing the temperature of the loaded gel structure is accomplished by exposing the loaded gel structure to body temperature or an external fluid.
REFERENCES:
patent: 5603955 (1997-02-01), Gehrke et al.
patent: 5840338 (1998-11-01), Roos et al.
patent: 5932248 (1999-08-01), Chen et al.
patent: 0177893 (1986-04-01), None
M.S. Thesis McBride et al 1996.
Fisher John P.
Gehrke Stevin H.
McBride James F.
Evans Charesse
Kenyon & Kenyon
Page Thurman K.
Sci-Med Life Systems, Inc.
LandOfFree
Temperature controlled solute delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Temperature controlled solute delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Temperature controlled solute delivery system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3225877